Congress Delays OMB Grantmaking Rule with Stopgap Funding Bill
Office of Management and Budget Director Russell Vought (right) at a cabinet meeting in July 2026.
Jacquelyn Martin / AP
The House voted Tuesday to fund the government and to block a controversial White House plan to overhaul federal grantmaking
This version of the bill, which passed
The bill also staves off the original Sept. 30 deadline for Congress to pass funding bills for fiscal year 2027.
Colette Delawalla, founder and CEO of the advocacy organization Stand Up for Science, celebrated the bill’s passage. “This is a win and would not have happened without the activism of many thousands of individual scientists and the pro-science public,” Delawalla said. “That said, it is the first step in seeing the OMB proposed rule revoked. It should never see the light of day and we will continue to fight against its implementation.”
OMB has so far reviewed almost 165,000 comments
Based on the wording in the funding bill, it seems that OMB staff could still work on finalizing the rule and responding to comments, said Stuart Shapiro, dean of the Edward J. Bloustein School of Planning and Public Policy at Rutgers University.
“I should note we are talking as if OMB will follow the law, and that is an assumption in this administration, not a given,” Shapiro added.
The funding bill would block rules “arising out of” OMB’s notice of proposed rulemaking or “substantially similar” rules. It remains unclear how this provision will impact similar revisions to regulations at agencies like the National Science Foundation
Krystal Toups, director of contracts and grant administration at COGR, said NSF could move forward with implementing its new regulations, even if the funding bill becomes law. However, she added that NSF has indicated it will have a second comment period before finalizing its new regulations. “NSF will review the public’s comments on the topic and hopefully respond accordingly,” Toups said.
Kei Koizumi, a senior advisor at the Union of Concerned Scientists, said it would be “wildly premature” for NSF to implement its proposed changes when the OMB rule could still be blocked by Congress or the courts.
NSF declined to comment on the bill’s impact on its proposed grantmaking changes.
Congressional support for the stopgap
The House voted overwhelmingly in favor of the bill, 370–48, despite earlier Republican support for OMB’s grantmaking proposal. In June, House Republicans rejected two attempts
Before the vote on Tuesday, DeLauro spoke in favor of the added provision and said there is bipartisan opposition to OMB’s proposal.
“More must be done to permanently block this policy before it is allowed to take effect,” DeLauro added. “Federal funding must be awarded as Congress intended, based upon genuine need and objective merit. Funding for cancer research should not be blocked because of partisan politics.”
House Appropriations Committee Chair Tom Cole (R-OK) did not call out the provision but expressed support for the bill. He called on the Senate to issue its appropriations bills to fund the government through fiscal year 2027. The Senate will return from recess on Sept. 14.
Democrats in both chambers have loudly opposed the OMB proposal, joined by Senate Committee Chair Susan Collins (R-ME). In July, all Senate Democrats called for